Survival after allo-SCT. (A-B) DFS (A) and OS (B) of the whole population. (C-D) DFS (C) and OS (D) for patients allografted in CR1 (dashed lines) or more advanced status (solid lines). (E-F) DFS (E) and OS (F) for patients younger (solid lines) and older (dashed lines) than 41 years of age. The median age of the younger group was 24 years (range, 9-40) and the median age of the older group was 57 years (range, 41-70). P values were calculated by log-rank test.